-
21
-
22
-
23
-
24
-
25
-
26
-
27
Average stability values (mean ± standard deviation) and statistical results.
Published 2024Subjects: -
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; <sup>$</sup>(P < 0.05) significant vs. …”
-
37
Marginal means – Pooled across scenarios.
Published 2025“…A randomized conjoint experiment and a follow-up choice experiment revealed that support for the EIAs decreased sharply as their accuracy gap grew, although impact parity was prioritized more when ETAs produced large outcome discrepancies. …”
-
38
-
39
-
40